The Journal of Organic Chemistry
Article
CH3CN (1 mL). CH3CN was evaporated under vacuum, and the
Celite powder was subjected to flash chromatography (ethyl acetate/
CH3CN 1:1). The product was obtained as a transparent oil (160 mg,
0.40 mmol, 28%) that was submitted in the subsequent step without
saturated aqueous solution of NaHCO3 was carefully added. The
formed brown precipitate was collected by filtration and purified by
flash chromatography (CH2Cl2/ethyl acetate 8:2) affording the
product 6 (1.1 g, 2.6 mmol, 77%) as a white powder. Mp: 109−114
1
1
further purification (MIDA is present as a residual impurity; see H
°C. H NMR (CDCl3): δ 8.84 (s, 2H), 7.92 (s, 2H), 4.19 (d, J = 6.7
and 13C NMR spectra in the Supporting Information). 1H NMR
(DMSO-d6): δ 8.64 (d, J = 5.2 Hz, 1H), 7.67 (d, J = 1.3 Hz, 1H), 7.63
(d, J = 3.6 Hz, 1H), 7.54 (dd, J = 2.0, 5.1 Hz, 1H), 6.94 (d, J = 3.6 Hz,
2H), 4.40 (d, J = 17.0 Hz, 2H), 4.10 (d, J = 17.0 Hz, 2H), 2.84 (t, J =
7.5 Hz, 4H), 2.60 (s, 3H), 1.66 (quin, 7.5 Hz, 2H), 1.4−1.2 (m, 6H),
0.87 (t, J = 7.0 Hz, 3H). 13C NMR (CD3CN): δ 168.6 (C, 2C), 150.5
(CH, 1C), 148.5 (C, 1C), 140.2 (C, 1C), 138.6 (C, 1C), 126.0 (CH,
1C), 125.8 (CH, 1C), 122.7 (CH, 1C), 118.5 (CH, 1C), 62.1 (CH2,
2C), 46.7 (CH3, 1C), 31.3 (CH2, 1C), 31.2 (CH2, 1C), 29.8 (CH2,
1C), 28.4 (CH2, 1C), 22.3 (CH2, 1C), 13.3 (CH3, 1C). ESI-HRMS:
calcd for [M + H]+ C20H26BN2O4S 401.1701, found 401.1695.
2-Bromo-4-(2,4-dihexyloxyphenyl)pyridine (5c). A mixture of
4,4,5,5-tetramethyl-2-(2,4-dihexyloxyphenyl)-1,3,2-dioxaborolane18a
(499 mg, 1.23 mmol), 2-bromo-4-iodopyridine (349 mg, 1.23 mmol),
Pd(PPh3)4 (71 mg, 0.061 mmol), and Na2CO3 (208 mg, 1.96 mmol)
in THF (30 mL) and H2O (20 mL) was stirred under microwave
irradiation (100 W, 100 °C) for 30 min. THF was evaporated, and
H2O (20 mL) was added. The aqueous solution was extracted with
CH2Cl2 (3 × 50 mL). The organic layers were dried with Na2SO4, and
CH2Cl2 was evaporated. Flash chromatography (petroleum ether/
CH2Cl2 95:5) afforded 5c as a transparent oil (290 mg, 0.66 mmol,
54%). 1H NMR (CDCl3): δ 8.31 (d, J = 5.2 Hz, 1H), 7.70 (d, J = 1.0
Hz, 1H), 7.42 (dd, J = 1.5, 5.2 Hz, 1H), 7.26 (d, J = 8.4 Hz, 1H), 6.55
(dd, J = 2.3, 8.4 Hz, 1H), 6.52 (d, J = 2.3 Hz, 1H), 4.00−3.95 (m, 4H),
1.92−1.72 (m, 4H), 1.5−1.4 (m, 4H), 1.4−1.3 (m, 8H), 0.92 (t, J =
7.0 Hz, 3H), 0.90 (t, J = 7.0 Hz, 3H). 13C NMR (CDCl3): δ 161.5 (C,
1C), 157.4 (C, 1C), 149.3 (CH, 1C), 149.1 (C, 1C), 142.0 (C, 1C),
130.9 (CH, 1C), 128.0 (CH, 1C), 123.0 (CH, 1C), 118.6 (CH, 1C),
105.7 (CH, 1C), 100.2 (CH, 1C), 68.4 (CH2, 1C), 68.2 (CH2, 1C),
31.6 (CH2, 1C), 31.5 (CH2, 1C), 29.2 (CH2, 1C), 29.0 (CH2, 1C),
25.9 (CH2, 1C), 25.7 (CH2, 1C), 22.6 (CH2, 1C), 22.6 (CH2, 1C),
14.0 (CH3, 1C), 14.0 (CH3, 1C). ESI-HRMS: calcd for [M + H]+
C23H3379BrNO2 434.1689, found 434.1702; calcd for [M + H]+
C23H3381BrNO2 436.1669, found 436.1682.
Hz, 4H), 2.14 (sep, J = 7.6 Hz, 2H), 1.04 (d, 6.7 Hz, 12H). 13C NMR
(CDCl3): δ 163.8 (C, 2C), 155.5 (C, 2C), 151.9 (C, 2C), 141.8 (C,
2C), 124.7 (CH, 2C), 119.5 (CH, 2C), 72.2 (CH2, 2C), 27.8 (CH,
2C), 19.1 (CH3, 4C). ESI-HRMS: calcd for [M + Na]+
C20H22Cl2N2NaO4 447.0849, found 447.0856.
4′,4″-Dicarboxylic-2,2′:6′,2″:6″,2‴-quaterpyridine Diisobutyl
Ester (1a). Pd2dba3 (143 mg, 0.15 mmol) and 2-dicyclohexylphosphi-
no-2′,4′,6′-triisopropylbiphenyl (XPhos) (298 mg, 0.62 mmol) were
added to a Schlenk flask under ambient atmosphere. DMF (4 mL) and
isopropyl alcohol (IPA) (10 mL) were added under an argon
atmosphere. The mixture was stirred under argon at 100 °C for 1 h
and then injected by syringe at 50 °C to a Schlenk flask previously
charged with 6 (2.0 g, 4.7 mmol), 1b (3.6 g, 15 mmol), Cu(OAc)2
(946 mg, 5.2 mmol), and K2CO3 (7.2 g, 52 mmol) under an argon
atmosphere. The mixture was stirred under argon at 100 °C for 15 h.
An aqueous solution of NaOH 1 M (400 mL) was added at room
temperature and the mixture extracted with CH2Cl2 (3 × 50 mL). The
solvent was evaporated from the collected and dried organic layers
leaving a residue which was taken up with CH2Cl2 (1 mL) and
cyclohexane (50 mL). The product was isolated as a brown precipitate
1
(786 mg, 1.54 mmol, 33%). Mp: 170−175 °C. H NMR (CDCl3): δ
9.20 (d, J = 1.5 Hz, 2H), 9.04 (d, J = 1.5 Hz, 2H), 8.76 (d, J = 4.0 Hz,
2H), 8.70 (s, J = 8.0 Hz, 2H), 7.91 (dd, J = 2.0, 9.5 Hz, 2H), 7.39 (dd,
J = 5. 6, 1.5 Hz, 2H), 4.25 (d, J = 6.5 Hz, 4H), 2.21 (sep, J = 6.5 Hz,
2H), 1.10 (d, 6.7 Hz, 12H). 13C NMR (CDCl3): δ 165.5 (C, 2C),
156.8 (C, 2C), 155.8 (C, 2C), 155.3 (C, 2C), 149.3 (CH, 2C), 140.1
(C, 2C), 137.0 (CH, 2C), 124.2 (CH, 2C), 121.4 (CH, 2C), 120.6
(CH, 2C), 120.5 (CH, 2C), 71.8 (CH2, 2C), 27.9 (CH, 2C), 19.2
(CH3, 4C). ESI-HRMS: calcd for [M + Na]+ C30H30N4NaO4
5 3 3 . 2 1 5 9 , f o u n d 5 3 3 . 2 1 5 6 . A n a l . C a l c d f o r
C30H30N4O4·1/5cyclohexane: C, 71.05; H, 6.19; N, 10.62. Found: C,
70.62; H, 5.92; N, 10.26.
6,6‴-Dimethyl-4′,4″-dicarboxylic-2,2′:6′,2″:6″,2‴-quaterpyridine
Diisobutyl Ester (2a). A procedure similar to the synthesis of 1a was
applied starting from Pd2dba3 (28 mg, 0.031 mmol), XPhos (54 mg,
0.11 mmol), DMF (8 mL), IPA (2 mL), 6 (400 mg, 0.94 mmol), 2b
(934 mg, 3.8 mmol), Cu(OAc)2 (188 mg, 1.0 mmol), and K2CO3 (1.4
g, 10 mmol). After the reaction mixture was stirred for 15 h at 100 °C
under argon, an aqueous solution of NaOH 1 M (90 mL) was added
affording the product as a brown precipitate (105 mg, 0.19 mmol,
21%). Mp: 173−178 °C (cyclohexane). 1H NMR (CDCl3): δ 9.18 (d,
J = 1.2 Hz, 2H), 9.05 (d, J = 1.2 Hz, 2H), 8.48 (d, J = 7.8 Hz, 2H),
7.78 (t, J = 8.0 Hz, 2H), 7.25 (d, 7.7 Hz, 2H), 4.26 (d, J = 6.5 Hz, 4H),
2.68 (s, 6H), 2.20 (sep, J = 7.6 Hz, 2H), 1.11 (d, J = 6.7 Hz, 12H). 13C
NMR (CDCl3): δ 165.6 (C, 2C), 158.1 (C, 2C), 157.1 (C, 2C), 155.8
(C, 2C), 154.7 (C, 2C), 140.0 (C, 2C), 137.1 (CH, 2C), 123.8 (CH,
2C), 120.6 (CH, 2C), 120.3 (CH, 2C), 118.4 (CH, 2C), 71.7 (CH2,
2C), 27.9 (CH, 2C), 24.6 (CH3, 2C), 19.2 (CH3, 4C). ESI-HRMS:
calcd for [M + Na]+ C32H34N4NaO4 561.2472, found 561.2469. Anal.
Calcd for C32H34N4O4·1/5cyclohexane: C, 71.79; H, 6.61; N, 10.09.
Found: C, 71.95; H, 6.12; N, 9.75.
6,6‴-Dimethoxy-4′,4″-dicarboxylic-2,2′:6′,2″:6″,2‴-quaterpyri-
dine Diisobutyl Ester (3a). A procedure similar to the synthesis of 1a
was applied starting from Pd2dba3 (13 mg, 0.014 mmol), XPhos (27
mg, 0.050 mmol), DMF (4 mL), IPA (1 mL), 6 (200 mg, 0.47 mmol),
3b (373 mg, 1.41 mmol), Cu(OAc)2 (175 mg, 0.47 mmol), and
K2CO3 (389 mg, 2.8 mmol). After the reaction mixture was stirred for
15 h at 100 °C under an argon atmosphere, H2O (20 mL) was added
at room temperature and a black solid was collected by filtration and
taken up with CH2Cl2 (1 mL). Petroleum ether (50 mL) was added to
the resulting solution yielding the product as a brown solid (91 mg,
0.16 mmol, 34%). Mp: 202−207 °C. 1H NMR (CDCl3): δ 9.16 (d, J =
1.2 Hz, 2H), 9.02 (d, J = 1.2 Hz, 2H), 8.30 (d, J = 7.3 Hz, 2H), 7.78 (t,
J = 7.7 Hz, 2H), 6.85 (d, J = 8.2 Hz, 2H), 4.25 (d, J = 6.5 Hz, 4H),
4.11 (s, 6H), 2.20 (sep, J = 7.6 Hz, 2H), 1.13 (d, 6.7 Hz, 12H). 13C
4-(2,4-Dihexyloxyphenyl)-2-pyridinylboronic Acid MIDA Ester
(5b). The same procedure for the synthesis of 4b was applied using
triisopropyl borate (0.12 mL, 0.70 mmol), 5c (210 mg, 0.48 mmol),
THF (5 mL), n-BuLi (0.45 mL, 1.6 M in hexane), MIDA (241 mg,
0.82 mmol), and dry DMSO (5 mL). The product was obtained as a
transparent oil (91 mg, 0.18 mmol, 37%), which was submitted in the
1
subsequent step without further purification. H NMR (CD3CN): δ
8.66 (dd, J = 0.5, 5.2 Hz, 1H), 7.83 (d, J = 1.0 Hz, 1H), 7.50 (dd, J =
1.9, 5.1 Hz, 1H), 7.38 (d, J = 9.1 Hz, 1H), 6.67−6.60 (m, 2H), 4.15 (d,
J = 16.8 Hz, 2H), 4.08−4.02 (m, 4H), 3.83 (d, J = 16.8 Hz, 2H), 2.62
(s, 3H), 1.78 (quin, J = 7.1 Hz, 2H), 1.73 (quin, J = 7.1 Hz, 2H), 1.48
(quin, J = 7.1 Hz, 2H), 1.44 (quin, J = 7.1 Hz, 2H), 1.42−1.28 (m,
8H), 0.89 (t, J = 7.1 Hz, 3H), 0.61 (t, J = 7.1 Hz, 3H). 13C NMR
(CD3CN): δ 168.7, 161.3, 157.6, 149.4, 145.3, 131.3, 127.7, 123.6, 118
(covered by solvent peak; see the Supporting Information), 106.4,
100.2, 68.6, 68.2, 62.2, 46.8, 31.4, 31.3, 29.0, 28.9, 25.6, 25.5, 22.5,
22.3, 13.4, 13.4. ESI-HRMS: calcd for [M + H]+ C28H40BN2O6
511.2974, found 511.2985.
Diisobutyl 6,6′-Dichloro-2,2′-bipyridine-4′,4′-dicarboxylate (6).
m-Chloroperbenzoic acid (5.0 g, 29 mmol) was added to a solution
of diisobutyl 4,4′-bipyridinedicarboxylate25 (2.0 g, 5.6 mmol) in
CHCl3 (50 mL), and the mixture was stirred for 3 days at room
temperature. The solvent was evaporated under reduced pressure and
water was added. The aqueous mixture was extracted with CH2Cl2 (3
× 50 mL). The dried organic layers were evaporated to dryness,
affording diisobutyl-4,4′-bipyridinedicarboxylate dioxide as a yellow
1
solid (2.0 g, 5.2 mmol, 92%). H NMR (CDCl3): δ 8.34 (d, 6.8 Hz,
2H), 8.14 (d, J = 2.3 Hz, 2H), 7.98 (dd, J = 2.5, 7.0 Hz, 2H), 4.13 (d, J
= 6.7 Hz, 4H), 2.07 (sep, J = 7.6 Hz, 2H), 1.00 (d, J = 6.7 Hz, 12H). A
solution of diisobutyl-4,4′-bipyridinedicarboxylate dioxide (1.3 g, 3.5
mmol) in POCl3 (16 mL) was refluxed for 7 h. At room temperature, a
7953
dx.doi.org/10.1021/jo301226z | J. Org. Chem. 2012, 77, 7945−7956